Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Trevisan

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Pediatric Rheumatology Online Journal|March 5, 2026
Safety of intravenous use of anakinra in pediatric inflammatory conditions: a retrospective multicenter studyMarta Klanjscek, Matteo Trevisan, Serena Pastore, et al.
Pharmacological Research|August 15, 2022
SGLT2-inhibitors are effective and safe in the elderly: The SOLD studyMaria Elena Lunati, Vincenzo Cimino, Alessandra Gandolfi, et al.
Nature Communications|October 18, 2018
Multi-stage bioengineering of a layered oesophagus with in vitro expanded muscle and epithelial adult progenitorsLuca Urbani, Carlotta Camilli, Demetra-Ellie Phylactopoulos, et al.
The Journal of Clinical Endocrinology and Metabolism|August 16, 2024
Data-driven Thyroglobulin Cutoffs for Low- and Intermediate-risk Thyroid Cancer Follow-up: ITCO Real-world AnalysisGiorgio Grani, Silvia D'Elia, Efisio Puxeddu, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 2025
Prospective Validation of ATA Risk Score for Papillary Thyroid Microcarcinoma: An ITCO Real-World StudySimone De Leo, Giulia Brigante, Silvia D'Elia, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Pediatric Rheumatology Online Journal|March 5, 2026
Safety of intravenous use of anakinra in pediatric inflammatory conditions: a retrospective multicenter studyMarta Klanjscek, Matteo Trevisan, Serena Pastore, et al.
Pharmacological Research|August 15, 2022
SGLT2-inhibitors are effective and safe in the elderly: The SOLD studyMaria Elena Lunati, Vincenzo Cimino, Alessandra Gandolfi, et al.
Nature Communications|October 18, 2018
Multi-stage bioengineering of a layered oesophagus with in vitro expanded muscle and epithelial adult progenitorsLuca Urbani, Carlotta Camilli, Demetra-Ellie Phylactopoulos, et al.
The Journal of Clinical Endocrinology and Metabolism|August 16, 2024
Data-driven Thyroglobulin Cutoffs for Low- and Intermediate-risk Thyroid Cancer Follow-up: ITCO Real-world AnalysisGiorgio Grani, Silvia D'Elia, Efisio Puxeddu, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 2025
Prospective Validation of ATA Risk Score for Papillary Thyroid Microcarcinoma: An ITCO Real-World StudySimone De Leo, Giulia Brigante, Silvia D'Elia, et al.
Pageof 4